-
Innovation Ranking
NewInnovation Ranking – AXT Inc
AXT Inc (AXT) develops, manufactures and supplies semiconductor substrates. The company's product portfolio includes indium phosphide (InP), germanium (Ge), gallium arsenide (GaAs), boron trioxide (B2O3), raw and purified gallium. It also offers products which include gallium-magnesium alloy, and pyrolytic boron nitride (pBN) crucibles. AXT products find applications in areas such as light emitting diodes (LEDs), fiber optic and wireless telecommunications, lasers and for solar cells for space and terrestrial photovoltaic applications. The company operates in Europe, North America and Asia...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Gersizangitide in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gersizangitide in Diabetic Macular Edema report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gersizangitide in Diabetic Macular Edema Drug Details: Gersizangitide (AXT-107) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gersizangitide in Choroidal Neovascularization
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Gersizangitide in Choroidal Neovascularization Drug Details:Gersizangitide (AXT-107) is under development for the treatment of wet age...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gersizangitide in Wet (Neovascular / Exudative) Macular Degeneration
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Gersizangitide in Wet (Neovascular / Exudative) Macular Degeneration Drug Details:Gersizangitide (AXT-107) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gersizangitide in Macular Edema
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Gersizangitide in Macular Edema Drug Details:Gersizangitide (AXT-107) is under development for the treatment of wet age...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AXT-107
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AXT-107 Drug Details AXT-107 is under development for the treatment of wet age related...
-
Product Insights
Macular Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Macular Edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular edema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently associated with diabetes, where damaged blood vessels in the retina begin to leak fluids, including small amounts of blood, into the retina. Other causes include retinal vein occlusion, side effects of certain medications and certain genetic disorders, such as...